Refine your search
-
Authors
-
Item types
-
Topics
- *Clinical Trials as Topic
- *Diabetes Mellitus, Type 2/dt [Drug Therapy]
- *Diabetes Mellitus/dt [Drug Therapy]
- *Glucagon-Like Peptide-1 Receptor/ag [Agonists]
- *Hypoglycemic Agents/ad [Administration & Dosage]
- *Hypoglycemic Agents/tu [Therapeutic Use]
- *Insulin Glargine/ad [Administration & Dosage]
- *Peptides/ad [Administration & Dosage]
- Adult
- Animals
- Antibodies/im [Immunology]
- Antibody Formation
- Blood Glucose/de [Drug Effects]
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2/bl [Blood]
- Diabetes Mellitus, Type 2/co [Complications]
- Glucagon-Like Peptides/aa [Analogs & Derivatives]
- Humans
- Hypoglycemia/dt [Drug Therapy]
- Treatment Outcome
- Show more
- Show less
-
Collections
-
Languages